Cancer-related fatigue
Conditions
Interventions
treatment group:Symptomatic treatment and Buzhong Yiqi granule
control group:Symptomatic treatment
Sponsors
Renmin Hospital of Wuhan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Non-small cell lung cancer patients who met the Western diagnostic criteria for primary lung cancer and TNM stage ?-?, regardless of metastasis (refer to the Western diagnostic criteria for non-small cell lung cancer formulated by the Chinese Standard for the Diagnosis and Treatment of Primary Lung Cancer (2018 edition) and the eighth edition TNM staging of lung cancer formulated by the International Association for the Study of Lung Cancer (IASLC) in 2017); 2. Meeting the diagnostic criteria for cancer-related fatigue (CRF) (referring to the CRF diagnostic criteria proposed in the tenth Revision of the International Classification of Diseases (ICD-10)); 3. TCM syndrome was diagnosed as lung qi deficiency syndrome (refer to the lung cancer diagnosis and treatment plan of the National Administration of Traditional Chinese Medicine 11th Five-Year Plan Key Specialist Collaboration Group); 4. The estimated survival time is greater than 6 months; 5. KPS functional status score is greater than 60; 6. Aged between 18 and 80 years; 7. Willing to accept the treatment of this protocol, with good compliance and signed informed consent; 8. Those who have completed all antitumor therapy or are undergoing antitumor therapy are currently in the interval of antitumor therapy, and the interval period is longer than 30 days, which is sufficient to complete the treatment of this protocol.
Exclusion criteria
Exclusion criteria: 1. Those with mental illness who cannot complete the rating scale; 2. Allergic to clinical research drugs; 3. Pregnant or lactating patients; 4. Patients with severe hypertension, heart, liver, kidney, blood system diseases and complications; 5. Taking traditional Chinese medicine or proprietary Chinese medicine containing Buzhong Yiqi Granule.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional Assessment of Chronic Illness Therapy-Fatigue; | — |
Secondary
| Measure | Time frame |
|---|---|
| The Fatigue Symptom Inventory;Symptom Inwentory for TCM;Karnofsky Performance Score;Inflammatory factor; | — |
Countries
China
Contacts
Public ContactMei Shasha
Renmin Hospital of Wuhan University
Outcome results
None listed